Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-02-04 @ 5:19 AM
Study NCT ID:
NCT01633060
Status:
TERMINATED
Last Update Posted:
2019-01-30
First Post:
2012-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |